Revolution Medicines, Inc. <RVMD.O>: Wells Fargo raises target price to $240 from $167
RVMD•Related News
Delcath Systems Q2 Revenue USD 29.133 Million Vs. IBES Estimate USD 26.3 Million
DCTH•
Aurinia Q2 net income climbs 74% to $37.4 million; revenue rises 19% to $83.2 million
AUPH•
ALX Oncology Q2 FY26 GAAP net loss narrows to $18 million; R&D expenses fall 27.2% to $13.1 million
ALXO•
Fox posts fiscal 2026 Q4, full-year earnings release report link
FOXA•
Helix returns to profit in Q2 FY26 with net income of $22.7 million; revenue rises 21% to $304 million vs Q2 FY25
HLX•